Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus

Clin Infect Dis. 2012 Apr;54(7):905-12. doi: 10.1093/cid/cir955. Epub 2012 Jan 11.

Abstract

Background: Respiratory syncytial virus (RSV) has been implicated in the etiology of adult community-acquired pneumonia (CAP). We investigated RSV infection in Chilean adults with CAP using direct viral detection, real-time reverse-transcription polymerase chain reaction (rtRT-PCR), and serology (microneutralization assay).

Methods: RSV, other respiratory viruses, and bacteria were studied by conventional and molecular techniques in adults aged ≥18 years presenting with CAP to the healthcare facilities in Santiago, Chile from February 2005 through December 2007.

Results: All 356 adults with CAP enrolled had an acute blood sample collected at enrollment, and 184 had a convalescent blood sample. RSV was detected in 48 cases (13.4%). Immunofluorescence assay and viral isolation each detected only 1 infection (0.2%), whereas rtRT-PCR was positive in 32 (8.9%) cases and serology was positive in 20 (10.8%) cases. CAP clinical characteristics were similar in RSV-infected and non-RSV-infected cases. RSV-specific geometric mean serum-neutralizing antibody titer (GMST) was significantly lower at admission in the 48 RSV-infected cases compared with 308 non-RSV-infected adults (GMST in log(2): RSV/A 8.1 vs 8.9, and RSV/B 9.3 vs 10.4; P < .02).

Conclusions: RSV infection is frequent in Chilean adults with CAP. Microneutralization assay was as sensitive as rtRT-PCR in detecting RSV infection and is a good adjunct assay for diagnostic research. High RSV-specific serum-neutralizing antibody levels were associated with protection against common and severe infection. The development of a vaccine could prevent RSV-related CAP in adults.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Neutralizing / blood*
  • Antibodies, Neutralizing / immunology
  • Antibodies, Viral / blood*
  • Antibodies, Viral / immunology
  • Chile / epidemiology
  • Clinical Laboratory Techniques / methods
  • Community-Acquired Infections / diagnosis
  • Community-Acquired Infections / epidemiology*
  • Community-Acquired Infections / immunology
  • Community-Acquired Infections / virology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neutralization Tests / methods
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / virology
  • Real-Time Polymerase Chain Reaction / methods
  • Respiratory Syncytial Virus Infections / diagnosis
  • Respiratory Syncytial Virus Infections / epidemiology*
  • Respiratory Syncytial Virus Infections / immunology
  • Respiratory Syncytial Virus, Human / immunology*
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Seroepidemiologic Studies
  • Young Adult

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral